Metabolomics approach reveals key plasma biomarkers in multiple myeloma for diagnosis, staging, and prognosis
Our findings on key metabolites and metabolic pathways provide novel insights into the exploration of diagnostic and therapeutic targets for MM. A prospective study is essential to validate these discoveries for future MM patient care.
Authors
- Guolin Shen (ORCID: https://orcid.org/0000-0003-2516-5349)
- Lili Gong (ORCID: https://orcid.org/0000-0002-0061-2029)
- Aijun Liu (ORCID: https://orcid.org/0000-0001-5159-7458)
- Lihong Liu (ORCID: https://orcid.org/0000-0003-4817-3173)
- Xiaoxue Wang
- Longhao Cheng
Institutions
- Capital Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- China-Japan Friendship Hospital (CN)
- Chinese Academy of Inspection and Quarantine (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1186/s12967-024-05848-7
- Citations
- 4
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 7.08
Funders
- China International Medical Foundation